Trial
NCT05983146
Phase I Study of HRS-7053 Injection in the Treatment of Patients With Advanced Malignancies
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Collaborators
—
Condition
Advanced Malignant Cancer
Intervention
HRS-7053 Injection
Why stopped
The sponsor's R\&D strategy is adjusted.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-24